68Ga-FAPI与18F-FDG PET/CT在癌症患者中的个体内头对头比较
该国际回顾性多中心研究纳入71例癌症患者,在 median 10天内均行68Ga-FAPI和18F-FDG PET/CT,比较生物分布与肿瘤摄取。结果显示两者肿瘤摄取相当,但68Ga-FAPI在多数正常器官背景摄取显著更低,部分部位(肝、骨转移)TBR显著更高。
要点
- 68Ga-FAPI与18F-FDG在原发灶和转移灶的肿瘤摄取大多相当。
- 68Ga-FAPI在脑、口腔黏膜、心肌、血池、肝、胰腺、结肠等背景摄取显著低于18F-FDG。
- 68Ga-FAPI在肝和骨转移等部位TBR显著高于18F-FDG。
核心结论
- 68Ga-FAPI与18F-FDG的定量肿瘤摄取相当,但68Ga-FAPI在多数正常器官背景摄取更低,导致TBR相等或更高。
研究设计与样本
- 国际回顾性多中心分析,纳入6个中心71例同时接受68Ga-FAPI和18F-FDG PET/CT的癌症患者,中位间隔10天(范围1-89天)。
- 手动勾画正常器官和肿瘤病灶的VOI,以SUVmax和SUVmean量化摄取,并计算肿瘤/背景比值(TBR,SUVmax肿瘤/SUVmax器官)。
主要发现
- 71例患者中女性28例、男性43例,中位年龄60岁;41例存在原发肿瘤,43例共162个转移灶。
- 68Ga-FAPI在原发肿瘤和转移灶的摄取在大多数病例与18F-FDG相当。
- 68Ga-FAPI在脑、口腔黏膜、心肌、血池、肝、胰腺和结肠等背景组织的SUVmax显著低于18F-FDG。
- 68Ga-FAPI在肝和骨转移等部位的TBR显著高于18F-FDG。
临床怎么用
- 68Ga-FAPI PET/CT可能为多种癌症提供更好的诊断信息,尤其在高生理性18F-FDG摄取部位的肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: FAPI ligands (fibroblast activation protein inhibitor), a novel class of radiotracers for PET/CT imaging, demonstrated in previous studies rapid and high tumor uptake. The purpose of this study is the head-to-head intra-individual comparison of 68Ga-FAPI versus standard-of-care 18F-FDG in PET/CT in organ biodistribution and tumor uptake in patients with various cancers. MATERIAL AND METHODS: This international retrospective multicenter analysis included PET/CT data from 71 patients from 6 centers who underwent both 68Ga-FAPI and 18F-FDG PET/CT within a median time interval of 10 days (range 1-89 days). Volumes of interest (VOIs) were manually drawn in normal organs and tumor lesions to quantify tracer uptake by SUVmax and SUVmean. Furthermore, tumor-to-background ratios (TBR) were generated (SUVmax tumor/ SUVmax organ). RESULTS: A total of 71 patients were studied of, which 28 were female and 43 male (median age 60). In 41 of 71 patients, the primary tumor was present. Forty-three of 71 patients exhibited 162 metastatic lesions. 68Ga-FAPI uptake in primary tumors and metastases was comparable to 18F-FDG in most cases. The SUVmax was significantly lower for 68Ga-FAPI than 18F-FDG in background tissues such as the brain, oral mucosa, myocardium, blood pool, liver, pancreas, and colon. Thus, 68Ga-FAPI TBRs were significantly higher than 18F-FDG TBRs in some sites, including liver and bone metastases. CONCLUSION: Quantitative tumor uptake is comparable between 68Ga-FAPI and 18F-FDG, but lower background uptake in most normal organs results in equal or higher TBRs for 68Ga-FAPI. Thus, 68Ga-FAPI PET/CT may yield improved diagnostic information in various cancers and especially in tumor locations with high physiological 18F-FDG uptake.
引用
- Giesel FL, Kratochwil C, Schlittenhardt J, et al. Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients. Eur J Nucl Med Mol Imaging. 2021. PMID: 34137945. doi:10.1007/s00259-021-05307-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。